Acute Myelogenous Leukemia (AML)
2 competing products in clinical development for Acute Myelogenous Leukemia (AML).
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| decitabine Induction Chemotherapy + Induction Chemotherapy | Eisai | Phase 2 | Withdrawn | 27 |
| KW-2449 | Kyowa Kirin | Phase 1 | Terminated | 21 |